Who is sponsoring NCT02622412?

NCT02622412 is sponsored by Ludwig-Maximilians - University of Munich.

What drugs are being tested in NCT02622412?

Interventions in NCT02622412: Multi-professional breathlessness service (MBS), Delayed MBS Intervention.

What condition does NCT02622412 study?

NCT02622412 studies Breathlessness, COPD, Cancer, Chronic Heart Failure, Interstitial Lung Disease.

Is NCT02622412 still recruiting?

NCT02622412 is currently completed. Last updated 9 August 2019.

Last reviewed 2019-08-09 · How we verify

NCT02622412: BreathEase

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of a Multi-professional Breathlessness Service for Patients With Breathlessness Due to Any Advanced Disease

Completed NA Last updated 9 August 2019

What this trial tests

NA trial testing Multi-professional breathlessness service (MBS) in Breathlessness in 183 participants. Completed in 30 April 2019.

Timeline

2 March 2015

Primary endpoint
1 February 2019

30 April 2019

Quick facts

Lead sponsor	Ludwig-Maximilians - University of Munich
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	183
Start date	2 March 2015
Primary completion	1 February 2019
Estimated completion	30 April 2019
Sites	1 location across Germany

Drugs / interventions tested

Multi-professional breathlessness service (MBS)
Delayed MBS Intervention

Conditions studied

Breathlessness — all drugs for Breathlessness →
COPD — all drugs for COPD →
Cancer — all drugs for Cancer →
Chronic Heart Failure — all drugs for Chronic Heart Failure →

Sponsor

Ludwig-Maximilians - University of Munich

Who can join

18 and older, any sex, with Breathlessness or COPD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Breathlessness is a common and distressing symptom in patients with advanced diseases like cancer, chronic obstructive pulmonary disease (COPD), chronic heart failure (CHF) or lung fibrosis, which broadly impacts on patients' quality of life and may result in high burden for carers. This single-blinded randomized controlled fast track trial evaluates the effectiveness of a multi-professional breathlessness service in patients with advanced and chronic diseases. The intervention group will get immediate access to the breathlessness service whereas the control group will receive standard care and get access to the service after a waiting time of eight weeks. Primary endpoints are mastery of breathlessness and quality of life, measured with the CRQ (Chronic Respiratory Questionnaire) as well as the reduction of symptom burden of patients and burden of carers. The evaluation of the cost effectiveness of the breathlessness service from the perspective of the German health system is a further study aim.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

BreathEase: rationale, design and recruitment of a randomised trial and embedded mixed-methods study of a multiprofessional breathlessness service in early palliative care.
Schunk M, Berger U, Le L, Rehfuess E, et al · · 2021 · cited 2× · PMID 34671668 · DOI 10.1183/23120541.00228-2020

Verify or expand the search:

Other recruiting trials for Breathlessness

Currently open trials in the same condition.

NCT07432893 — Assessing the Effectiveness of Large Language Model (LLM)-Enabled Nurse Treatment Planning in 2 Indian Districts · NA · recruiting
NCT07281300 — Mindfulness-Oriented Respiratory Distress Symptom Intervention for Lung Cancer · NA · recruiting

Other Ludwig-Maximilians - University of Munich trials

Trials by the same sponsor.

NCT07514520 — Decision-making, Ethical Consent, and Interactive Dialogue in Ongoing Neurocognitive Decline - DECISION · active not recruiting
NCT07504965 — Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly · recruiting
NCT07100548 — A Qualitative Analysis of Youth Responses to Depression Education Delivered on Social Media · completed
NCT07061600 — Enhancing Depression Literacy and Reducing Stigma in Adolescents Through Social Media · NA · completed
NCT06749106 — Plaque Imaging in Routine Care to Detect Intraplaque Hemorrhage · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02622412 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ludwig-Maximilians - University of Munich
Last refreshed: 9 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02622412.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing